Skip to content

Comparing Post-Surgical Symptoms: Gastric Sleeve With and Without Omentopexy Comparing Post-Surgical Symptoms: Gastric Sleeve With and Without Omentopexy Comparison of Postoperative Symptoms: Gastric Sleeve With and Without Omentopexy.

POST-SURGICAL SYMPTOMS IN PATIENTS UNDERGOING GASTRIC SLEEVE SURGERY: OMENTOPEXY VS. NO OMENTOPEXY

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06396832
Enrollment
53
Registered
2024-05-02
Start date
2022-05-01
Completion date
2024-04-01
Last updated
2024-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Procedure, Unspecified

Keywords

Omentopexy, Complications, Metabolic surgery

Brief summary

Metabolic surgery has proven to be an effective treatment for obesity, with laparoscopic sleeve gastrectomy being the most popular procedure. Omentopexy (OP) is proposed as a strategy to reduce associated complications. Objective was to determine the effectiveness of omentopexy in controlling post-surgical symptoms and to measure the need for re-intervention, leakage, bleeding, and mortality in patients undergoing laparoscopic sleeve gastrectomy.

Detailed description

Patients who underwent laparoscopic sleeve gastrectomy (LSG). Of these patients, 53 received LSG with omentopexy (OP) and 52 underwent LSG without omentopexy (NO OP) between 2022 and 2023. Each group was attended by a different surgeon. The analysis focused on data concerning gastrointestinal symptoms recorded 24 hours postoperatively, as well as documented cases of bleeding, leakage, re-operation, and mortality during the hospitalization period

Interventions

None listed

Sponsors

Instituto Mexicano del Seguro Social
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Diagnosis of obesity * Adults over 18 years old * Undergoing sleeve gastrectomy * Consent to respond to the immediate postoperative symptom questionnaire

Exclusion criteria

* Repair of hiatal hernia * Refusal to complete the evaluation instrument * Unavailability of medical records

Design outcomes

Primary

MeasureTime frameDescription
Postoperative gastrointestinal symptoms24 hourspatients undergoing sleeve gastrectomy with omentopexy for obesity treatment will be lower compared to those undergoing sleeve gastrectomy without adjuncts.

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026